Experimental AML combo studied in older patients, trial stopped early
Disease control
Terminated
This early-stage study tested a three-drug combination (uproleselan, azacitidine, and venetoclax) in 16 older or medically unfit adults with untreated acute myeloid leukemia (AML). The goal was to find the safest dose and check for side effects. The trial was terminated early, so…
Phase: PHASE1 • Sponsor: Brian Jonas • Aim: Disease control
Last updated May 05, 2026 11:56 UTC